联合使用VHL和KEAP1 PROTACs揭示了意想不到的协同作用和效应缓解效应
Sehbanul Islam1, Haihong Jin2, Dong Liu2
1Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Genes & development
|December 8, 2025
概括
这项研究引入了一种使用两个E3链酶的双PROTAC策略,以增强蛋白质降解并克服针对性治疗中的效应等局限性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白解酶的仿真体 (PROTACs) 是双功能分子,通过将向蛋白与E3泛胺酶架桥来诱导蛋白质降解.
- 由于不活跃的二元复合体形成,PROTACs面临诸多挑战,包括低于最佳的目标降解和"效应",其中高度会抑制有效性.
研究的目的:
- 开发和评估一种新型的双PROTAC策略,采用两种不同的E3结合酶.
- 为了协同增强目标蛋白质如KRAS (G12D) 和雄激素受体 (AR) 的降解.
- 为了减轻传统PROTAC观察到的"效应".
主要方法:
- 采用了双PROTAC方法,涉及两个不同的E3链酶 (例如KEAP1和VHL).
- 研究了特定标蛋白,KRAS (G12D) 和AR的协同降解.
- 评估了双E3结合酶策略对无素链延长和"效应"的影响.
主要成果:
- 双PROTAC策略证明了目标蛋白 KRAS ((G12D) 和 AR 的协同降解.
- 这种方法促进了无处不在链的延长,从而导致更有效的降解.
- 双E3结合酶系统有效地减轻了"子效应",在较高度下提高了疗效.
结论:
- 双E3结合酶策略提供了一个有前途的方法来优化基于PROTAC的治疗方法.
- 这种方法提高了目标降解效率,克服了PROTAC的主要局限性.
- 双PROTAC系统代表了针对性蛋白质降解疗法的重大进步.
更多相关视频
05:28Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites
Published on: June 2, 2023
1.3K
12:09Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
10.2K
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K
